Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | 2-Bromothiazole | HCID 76430 | — |
| Solvent | 1-Butanol | HCID 263 | — |
| Product | 1-(Thiazol-2-yl)piperazine | HCID 911806 | 28.6% |
Reaction Steps
3.61 g (22.0 mmol) of 2-bromothiazole were dissolved in n-butanol (20 ml) together with 1.90 g (22.0 mmol) piperazine. The reaction solution was heated at 120° C. 3 h and stirred at RT a further 16 h. The precipitate formed was then filtered off and the filtrate was concentrated in vacuo. The residue was taken up in DCM, and a 1 M aq. sodium carbonate soln was added. After separation of the phases, the organic phase was dried over magnesium sulfate, filtered and concentrated in vacuo. A column chromatography (MeOH:DIPE 1:1) was carried out on the residue to give 1.06 g (6.3 mmol, 28% of theory) of 1-thiazol-2-ylpiperazine.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07300939B2 |
|---|
| Source dataset | uspto-grants-2007_11 |
|---|
| ORD ID | ord-7b2637a748db472791186dbacfadbfd7 |
|---|
| Source note | uspto-grants-2007_11 |
|---|